Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$4.65 - $7.23 $74,400 - $115,680
-16,000 Closed
0 $0
Q3 2021

Oct 27, 2021

BUY
$7.41 - $10.99 $118,560 - $175,840
16,000 New
16,000 $108,000
Q2 2021

Jul 13, 2021

SELL
$6.35 - $10.0 $101,600 - $160,000
-16,000 Closed
0 $0
Q1 2021

Apr 13, 2021

BUY
$7.03 - $16.51 $112,480 - $264,160
16,000 New
16,000 $111,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Tl Private Wealth Portfolio

Follow Tl Private Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tl Private Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Tl Private Wealth with notifications on news.